New perspectives with interferon alpha. The German CML study group experience.
Hehlmann
R
R
III. Medizinische Klinik, Klinikum Mannheim, Universität Heidelberg, Germany.
Ansari
H
H
Adelberger
V
V
Heinze
B
B
Hossfeld
K
K
Hochhaus
A
A
Heimpel
H
H
D002066:Busulfan / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D016898:Interferon-alpha; D002066:Busulfan; D006918:Hydroxyurea